Improving Control of Alignment in Intermittent Exotropia
NCT ID: NCT04199871
Last Updated: 2025-01-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
84 participants
INTERVENTIONAL
2021-03-25
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Control of Intermittent Exotropia
NCT07272005
Observation Versus Occlusion Therapy for Intermittent Exotropia
NCT01032330
Using Dichoptic Therapy to Treat Intermittent Exotropia
NCT06529016
Trial of Vision Therapy for Intermittent Exotropia
NCT04487249
Full-Time Occlusion Therapy for Intermittent Exotropia in Children
NCT05462821
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Poor surgical results for IXT are thought to occur due to poor sensory status (suppression) or inadequate motor alignment. There are few data on the effects of non-surgical interventions designed to improve sensory status of children undergoing surgery for IXT. Although several retrospective case reviews found evidence supporting a benefit of pre-op sensory and motor fusion training on IXT surgical outcomes, there have been no prospective studies or randomized clinical trials. One of the largest retrospective case series (Cooper \& Leyman 1977; Am Orthoptic J 27:61-7) compared 216 patients with IXT who had sensory and motor fusion training prior to surgery with 264 who had surgery alone and found a higher rate of good surgical outcomes (52% vs 42%). There are no published data on post-op interventions to improved sensory status.
In this study, engaging movies will be presented on a handheld Nintendo to decrease suppression and engage stereoacuity. In previous research, use of dichoptic games and movies by children with amblyopia has been shown to reduce suppression and encourage sensory fusion (Birch et al 2015, JAAPOS 19:6-11; Birch et al 2019, JAAPOS \[Epub ahead of print\]; Kelly, Jost, et al 2016; JAMA Ophthalmol 134:1402-8.; Kelly et al Invest 2018 Ophthalmol Vis Sci 59:1221-8; Li et al 2014; Eye 28: 1246-53). This approach will be adapted by using dichoptic movies presented on a Nintendo for children with IXT to improve their stereoacuity and reduce their suppression in an effort improve control of alignment sufficiently without surgery (Aim 1) or to improve stability of post-operative alignment (Aim 2).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group1
dichoptic 3D movies
dichoptic 3D movies
dichoptic movies presented on a Nintendo 3DS
Group 2
dichoptic standard movies
dichoptic 3D movies
dichoptic movies presented on a Nintendo 3DS
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
dichoptic 3D movies
dichoptic movies presented on a Nintendo 3DS
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* IXT control assessment score at distance of 3 or 4 at baseline
* Ocular misalignment by PACT \>10 pd at distance and near or PACT \>15 at distance or near
Exclusion Criteria
* Prior surgery
* Prior binocular treatment
* Coexisting ocular or systemic condition
* Developmental delay
3 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Retina Foundation of the Southwest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eileen Birch
Senior Research Scientist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eileen E Birch, PhD
Role: PRINCIPAL_INVESTIGATOR
Retina Foundation of the Southwest
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eileen E Birch
Dallas, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STU-2019-1430
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.